Annual report pursuant to Section 13 and 15(d)

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)

12 Months Ended

Dec. 31, 2021

Schedule of the Computation of Basic and Diluted Net Loss Per Share of Common Stock

The following tables set forth the computation of basic and diluted net (loss) income per share of common stock for and preferred stock for the years ended December 31, 2021 and 2020 (in thousands, except per share amounts):


	Year Ended
	December 31, 2021
	Common stock				Preferred Stock
	Continuing Operations		Discontinued Operations		Continuing Operations		Discontinued Operations
Numerator:
Allocation of undistributed net (loss) income	$	(82,849)	$	(27)	$	(1,500)	$	—
Denominator:
Weighted average shares	99,888,447		99,888,447		361,644		361,644
Basic and diluted net (loss) income per share	$	(0.83)	$	0.00	$	(4.15)	$	0.00


	Year Ended
	December 31, 2020
	Common stock				Preferred Stock
	Continuing Operations		Discontinued Operations		Continuing Operations		Discontinued Operations
Numerator:
Allocation of undistributed net (loss) income	$	(58,440)	$	802	$	(5,944)	$	82
Denominator:
Weighted average shares	66,688,464		66,688,464		1,356,597		1,356,597
Basic and diluted net (loss) income per share	$	(0.87)	$	0.01	$	(4.38)	$	0.06

Schedule of Anti-dilutive Securities Excluded from Computation of Diluted Weighted Shares Outstanding

The following outstanding securities at December 31, 2021 and 2020 have been excluded from the computation of diluted weighted shares outstanding, as they could have been anti-dilutive:


	December 31,
	2021	2020
Stock options	13,650,978	9,830,674
Warrants on common stock1	4,406,224	4,002,380
Restricted Stock Units	11,250	155,833

1 The weighted average number of common shares outstanding as of December 31, 2021 includes the weighted average effect of the 1,676,923 pre-funded warrants issued in connection with the underwritten public offering that closed in January 2021 because the exercise of such warrants requires nominal consideration ($0.001 per share exercise price for each pre-funded warrant). 308,880 of the pre-funded warrants have been exercised. Therefore, the 1,368,043 pre-funded warrants outstanding as of December 31, 2021 are not included in the table above.